Programmed cell death, also known as apoptosis, is frequently initiated when cells are deprived of specific trophic factors. To investigate if accelerated apoptosis contributes to the pathogenesis of Diamond-Blackfan anemia (DBA), a rare pure red blood cell aplasia of childhood, we studied the effect of erythropoietin (epo) deprivation on erythroid progenitors and precursors from the bone marrow of DBA patients as compared with hematologically normal controls. Apoptosis in response to epo deprivation was evaluated by enumeration of colony-forming unit-erythroid (CFU-E)-and burst-forming unit-erythroid (BFU-E)-derived colonies in plasma clot semisolid culture and by the identification of typical DNA digosomes by gel electrophoresis from marrow mononuclear cells in liquid culture. In all DBA patients there was a marked decrease in CFU-E-and BFU-E-derived colony formation compared with normal controls at IAMOND-BLACKFAN anemia (DBA) is a rare pure red blood cell (RBC) aplasia of childhood characterized by moderate to severe anemia, reticulocytopenia, macrocytosis, and in the vast majority ofcases, a paucity of bone marrow (BM) erythroid precursors.' There is usually no leukopenia or thrombocytopenia with normal precursors of these elements present in the BM.' The syndrome is associated with a variety of somatic malformations in less than 30% of cases.' Since the first description of DBA over 50 years ag0,~3~ there have been a number of theories put forth regarding its etiology. Recent investigators have suggested humoral5 or cellular6~' suppression of erythropoiesis, a microenvironmental defect,' a block in maturation between the multipotent myeloid progenitor and the earliest erythroid progenitor: accessory cell failure," and an intrinsic progenitor defect.'','2 Despite reports of immunologic abnormalities and microenvironmental or accessory cell defects in some patients with DBA, the consensus among investigators is that the majority of cases appear to result from an intrinsic disorder of the erythroid progenitor that involves its inability to respond normally to inducers of erythroid proliferation and differentiation. The most thoroughly studied inducers include erythropoietin (epo)," interleukin-3 (1L-3),l3-Is and stem cell Of particular note, no receptor-ligand defects have yet been identified.15 Thus, the specific nature of what is probably a heterogenous disorder, remains unknown.
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Recent work by Khoury and Bondurantl'.'' shows that apoptosis, or programmed cell death, is an important control mechanism for erythropoiesis and that the phenomenon is initiated when epo-sensitive cells are deprived of the hormone. Apoptosis, in fact, is induced when appropriate growth factors are withheld in many different cell syst e m~. '~-~' Cells undergoing apoptosis are characterized by nuclear chromatin condensation and a contraction of cell volume.2' Although the cells are metabolically and synthetically active with preservation of organelle and cell-membrane integrity, in apoptosis there is degradation of chromosomal DNA induced by a calcium-dependent endonuclease comparable time points of epo deprivation, with a complete loss of CFU-E-derived colonies in semisolid culture by 9 hours of epo deprivation versus 48 hours in controls.
The BFU-E-derived colony response to epo deprivation displayed a similar pattern of decrement. Apoptotic changes assessed by the presence of characteristic DNA fragmentation began in the absence of epo deprivation and were readily detected within 3 hours of epo deprivation in DBA cultures versus 9 hours in controls. We conclude that DBA is characterized by accelerated apoptosis as measured by the loss of erythroid progenitor clonogenicity and increased progenitor and precursor DNA fragmentation leading to the formation of characteristic oligosomes, consistent with an intrinsic erythroid-progenitor defect in which increased sensitivity to epo deprivation results in erythroid! failure. Khoury and Bondurant'' note that the previously reported loss of clonogenicity of normal erythroid progenitors in semisolid culture, in proportion to the duration of epo deprivation,23 is a likely consequence of apoptosis. Based on these observations, the current study was undertaken to test the hypothesis that DBA is characterized by erythroid progenitors and precursors highly susceptible to apoptosis, as demonstrated by the accelerated loss oferythroid progenitor clonogenicity, and the concomitant appearance of typical DNA oligosomes in the face of epo deprivation. Patient LV, female, was diagnosed at 7 weeks of age. Initially treated with prednisone, the therapy was discontinued because of PERDAHL AL Abbreviations: CBC, complete blood count; PRBC, packed red blood cell; NA, not available. * Initial steroid response followed by a progressive decrease in response resulting In dose increments leadmg to steroid refractiveness (LV, PM) and/ or severe toxicity (ML, LV).
MATERIALS AND METHODS

Subjects
severe growth retardation, osteopenia and ultimately steroid refractoriness. She had been on chronic red blood cell transfusions and desferal chelation, in good iron balance, for 6 years at the time of the study. She has multiple skeletal abnormalities including a foreshortened metacarpal bone and distal phalanx of the left thumb. There was consanguinity five generations ago and the patient and her brother both have ocular albinism unrelated to DBA. ML, male, was diagnosed at six weeks ofage. He was initially treated daily, then on alternate days, with prednisone resulting in a good response. A progressive decrease in steroid responsiveness followed requiring increasing doses until age 13 years when steroid treatment was discontinued because of aseptic necrosis of the calcaneus. He had been on chronic RBC transfusions and desferal chelation, in good iron balance, for 7 years at the time of the study. He has short stature but is otherwise normal. Patient JK, male, was diagnosed at 5 weeks of age. The patient never responded to prednisone and therefore, is
Hours of Epo Dsprlvation chronically transfused and on desferal chelation with moderate iron balance. He has a hypoplasic left hand with five underdeveloped digits, a decreased radial pulse, and a symmetrically short left forearm, consistent with amniotic band syndrome, felt to be unrelated to DBA. Patient PM, female was diagnosed at 2 2/ 12 years of age. She responded initially to prednisone and was tapered to an everyother-day dose. She became anemic when steroids were discontinued and she received her first transfusion at 24 years of age. Prednisone was reinstituted and she did well until she was 31 years old when she became gradually RBC-transfusion dependent. Her physical exam, other than for mild corticosteroid effects, was unremarkable. YD, male, was diagnosed at 6 weeks of age. He was initially treated daily with methylprednisolone showing no improvement. He required 6 U of packed RBCs during his first year of life but has not been transfused since. Over the last three years, he has responded to oral prednisolone pulses of 30 mg/d for 3 days every 10 Table 3 . The t,,* max for BFU-E colony formation was approximately 3 hours for DBA versus 15 hours for controls. Plasma clot culture. DBA and normal BM low-density mononuclear cells (MNC) prepared by Ficoll Hypaque (Pharmacia, Uppsala, Sweden) density centrifugation were plated at 2 X IO5 cells/mL clot suspension in the plasma clot system previously described" and modifiedF6 Briefly, clotting was initiated by the addition of 0.1 U of grade 1 bovine thrombin (Sigma Biochemicals, St Louis, MO). The I .O-mL clotting mixture was dispensed in 0.1-mL aliquots into 0.2-mL microtitre culture wells (Linbro plates, Linbro Scientific, New Haven, CT) and incubated under 5% CO2 in high humidity. The culture system contained 2 U/mL recombinant human epo (Amgen, Thousand Oaks, CA) added either initially or as 0.2 U in 5 *L dripped on each 0.1-mL clot at the time points 3,6,9, I5 to 17, 24, 48, or 72 hours. The clots were harvested, fixed, and stained as described by McLeod et al." Erythroid colonies in at least three clots for each time point were counted and expressed as the number oferythroid colonies per IO5 cells plated. CFU-E were enumerated on day 7 and BFU-E on days 10 through I3 as previously described.23
Liquid suspension culture. Cells (5 to IO X IO6) were placed in RPM1 1640 (GIBCO, Grand Island, NY) containing 20% (vol/vol) heat-inactivated fetal calf serum (GIBCO, Grand Island, NY), 10% (vol/vol) bovine serum albumin (Sigma), 10% (vol/vol), asparagine (0.2 mg/mL) (Sigma) and 20% (vol/vol) NCTC-I09 (Whittaker Bioproducts, Walkersville, MD) at a concentration of I X IO6 cells/ mL. Recombinant human epo (Amgen) was added at a concentration of 2 U/mL to each flask according to a preset timetable, thus causing epo deprivation from 0 to 72 hours. The cells were harvested after 2 to 7 days in culture. Cell viability was confirmed by trypan blue exclusion.
DNA extraction. DNA extraction was performed by either phenol/chloroform or high-salt extraction. In phenol/chloroform extraction, harvested cells were resuspended in extraction buffer (1 50 mmol/L NaCI, 10 mmol/L EDTA pH 8.0, 10 mmol/L Tris pH 7.5 and 0.1% sodium dodecyl sulfate [SDS]). RNAse A (1 mg/mL), (Sigma) was added and the sample incubated for 0.5 to 3 hours at 37°C. Proteinase K (2 mg/mL) (Sigma) was added to the sample for digestion at 37°C overnight. The phenol/chloroform extraction was preformed as described by Maniatis et aL2' For high-salt extraction, DNA was extracted as described by Miller et aI2* with the addition of RNAse A digestion before the addition of Proteinase K. No difference in DNA quantity or quality was noted between the two extraction methods (data not shown). The addition of RNAse A incubation to remove RNA contamination from this assay does not compromise the DNA quality (data not shown). The amount and purity of DNA obtained was quantified by A260,280 in a Beckman DU-64 Spectrophotometer (Beckman Instruments, Pasadena, CA).
Polyacrylamide gel electrophoresis (PAGE). Acrylamide solution for 0.75 mm thick 7 mol/L Urea, 8% polyacrylamide gel (acrylamide: bis-acrylamide 19: I ) was prepared as described by Davis et with 1 X TBE (0.089 mol/L tris-borate, 0.089 mol/L boric acid, and 0.008 mol/L EDTA) as running buffer. 
RESULTS
Colon!. c.vprc~ssion us U ,/irnction (?S epo dcprivution.
When CFU-E-derived colonies were enumerated as a function of the duration of epo deprivation in semisolid plasma clot culture there was a 5070 loss of colony-forming capability (tl12max) at approximately 3 hours in two DBA patients (LV and YD) compared with a mean of9 hours for the four controls (Fig 1 A) . A total loss of CFU-E colony expression was noted by 9 hours in the DBA patients. whereas it required 48 hours of epo deprivation for total colony loss in the controls. CFU-E-derived colony counts are enumerated in Table 2 . The BFU-E-derived colony response to epo deprivation displayed a similar pattern of decrement (Fig l B) . However, there was a greater shift in the t,,? max from less than 3 hours for the two DBA patients to approximately I2 hours for the controls. In addition, a small number of BFU-E-derived colonies from controls more resistant to epo deprivation were noted. These more resistant colonies most likely represent the most immature, less epo-dependent BFU-E. This pattern is consistent with previous studies of hematologic normals.23 BFU-E-derived colony counts are enumerated in Table 3 .
DNA ,frugtneniution us U /irnciion of cpo deprivation.
The time course for DNA fragmentation as a function of epo deprivation was noted to be accelerated in DBA patients as evaluated by PAGE. DNA fragmentation observed at 0 hours of epo deprivation in DBA patients was in excess of that seen in controls at 0 hours, and was shown to increase by 3 hours of epo deprivation, whereas no significant increase in low molecular-weight DNA was apparent in the control until 9 to I5 hours ofepo deprivation. A representative study, patient YD versus control, is shown in Fig 2. Total DNA degradation probably accounts for the decrease in low molecular DNA observed at 24 hours in the DBA patient. The presence of DNA fragmentation at 0 hours ofepo deprivation most likely represents physiologic" apoptosis and/or apoptosis occurring during processing ofthe marrow before culture.
Because of the heterogenous nature of BM MNCs, the ethidium bromide stain did not show the distinct DNA ladder" indicative of apoptosis when homogenous cell populations or cell lines are evaluated. To show that the appearance of this low molecular-weight DNA was a consequence of apoptosis, rather than nonspecific degradation S-end DNA labeling was used to increase the signal of these small fragments. Distinct oligosomes of 180 and 360 bp were noted at 3 hours in the DBA patient. Densitometry of the autoradiograph in Fig 4 quantitates the appearance of these distinct DNA oligosomes by 3 hours of epo deprivation. Typical oligosomes of 180 and 360 bp seen in DBA patients by 3 hours were not identified in normal controls until 9 to 15 hours of epo deprivation (data not shown). Comparable oligosome formation was again confirmed with this technique in 3 additional patients (PM, JB, and OT) in studies using fewer epo delay time points (Fig 5) . showing that the low molecularweight DNA resulting from epo deprivation is in the form of typical oligosomes characteristic of apoptosis.
DISCUSSION
Erythroid progenitors from patients with DBA were noted to have increased susceptibility to apoptosis as shown by the accelerated loss of clonogenicity in semisolid culture and an accelerated increase in characteristic DNA fragmentation when erythroid cells are deprived of epo. This finding is consistent with the proposed intrinsic erythroid-progenitor defect in which an abnormality in hematopoietic growth-factor responsiveness leads to the observed erythroid failure in DBA."
Indeed apoptosis as a mechanism of cell death has been described for other hematopoietic cells when appropriate growth factors (eg, granulocyte-macrophage colony-stimulating factor, IL-3) have been withheld.'" suggesting a common mechanism of proliferation control in which hematopoietic cells are programmed to die in the absence of required growth factors. In DBA. where the erythroid progenitors are relatively insensitive to epo. either as the pri- mary defect or as a consequence of insensitivity to other growth factors, apoptosis may predominate over epo-induced proliferation and differentiation resulting in a decreased number and/or proliferative capacity of erythroid progenitors and precursors.
-
The pathways that lead to apoptosis are not completely understood and may differ in various cell types. The accelerated apoptosis noted in D B A may result from defective epo receptor-ligand interactions, abnormal intracellular signal transduction or even the erroneous initiation of apoptosis. A detailed understanding ofreceptor-epo interactions and the intracellular signalingevents that follow recep-
